Comparison of seizure reduction and serum fatty acid levels after receiving the ketogenic and modified Atkins diet

Seizure

Volumn 18, Issue 5, 2009, Pages 359-364

  Porta, Natacha ^a   Vallée, Louis ^a   Boutry, Elisabeth ^a   Fontaine, Monique ^a   Dessein, Anne Frédérique ^a   Joriot, Sylvie ^a   Cuisset, Jean Marie ^a   Cuvellier, Jean Christophe ^a   Auvin, Stéphane ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Antiepileptic drug; Arachidonic acid; Epilepsy; Ketogenic diet; Modified Atkins diet; Polyunsaturated fatty acids; Status epilepticus

Indexed keywords

ARACHIDONIC ACID; FATTY ACID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPTIC STATE; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INTERMETHOD COMPARISON; KETOGENIC DIET; LOW CARBOHYDRATE DIET; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; SEIZURE; TREATMENT DURATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIET, CARBOHYDRATE-RESTRICTED; FATTY ACIDS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; KETOGENIC DIET; MALE; RETROSPECTIVE STUDIES; SEIZURES; TIME FACTORS;

EID: 67349155546     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2009.01.004     Document Type: Article

References (32)

1. Picot M.C., Baldy-Moulinier M., Daures J.P., Dujols P., and Crespel A. The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country. Epilepsia (2008)
2. Sander J.W. The epidemiology of epilepsy revisited. Curr Opin Neurol 16 (2003) 165-170
3. Coppola G., Veggiotti P., Cusmai R., Bertoli S., Cardinali S., onisi-Vici C., et al. The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an Italian multicentric experience. Epilepsy Res 48 (2002) 221-227
4. Freeman J.M., Vining E.P., Pillas D.J., Pyzik P.L., Casey J.C., and Kelly L.M. The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics 102 (1998) 1358-1363
5. Neal E., Chaffe H., Schwartz R., Lawson M., Edwards N., Fitzsimmons G., et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol 7 (2008) 500-506
6. Vining E.P., Freeman J.M., Ballaban-Gil K., Camfield C.S., Camfield P.R., Holmes G.L., et al. A multicenter study of the efficacy of the ketogenic diet. Arch Neurol 55 (1998) 1433-1437
7. Kang H.C., Kim Y.J., Kim D.W., and Kim H.D. Efficacy and safety of the ketogenic diet for intractable childhood epilepsy: Korean multicentric experience. Epilepsia 46 (2005) 272-279
8. Carrette E., Vonck K., de Herdt V., Dewaele I., Raedt R., Goossens L., et al. A pilot trial with modified Atkins' diet in adult patients with refractory epilepsy. Clin Neurol Neurosurg 110 (2008) 797-803
9. Kang H.C., Lee H.S., You S.J., Kang D.C., Ko T.S., and Kim H.D. Use of a modified Atkins diet in intractable childhood epilepsy. Epilepsia 48 (2007) 182-186
10. Kossoff E.H., Krauss G.L., McGrogan J.R., and Freeman J.M. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology 61 (2003) 1789-1791
11. Kossoff E.H., McGrogan J.R., Bluml R.M., Pillas D.J., Rubenstein J.E., and Vining E.P. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia 47 (2006) 421-424
12. Kossoff E.H., Turner Z., Bluml R.M., Pyzik P.L., and Vining E.P. A randomized, crossover comparison of daily carbohydrate limits using the modified Atkins diet. Epilepsy Behav 10 (2007) 432-436
13. Kossoff E.H., Rowley H., Sinha S.R., and Vining E.P. A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia 49 (2008) 316-319
14. Porta N., Bourgois B., Galabert C., Lecointe C., Cappy P., Bordet R., et al. Anticonvulsant effects of linolenic acid are unrelated to brain phospholipid cell membrane compositions. Epilepsia 50 (2009) 65-71
15. Lauritzen I., Blondeau N., Heurteaux C., Widmann C., Romey G., and Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 19 (2000) 1784-1793
16. Rabinovitz S., Mostofsky D.I., and Yehuda S. Anticonvulsant efficiency, behavioral performance and cortisol levels: a comparison of carbamazepine (CBZ) and a fatty acid compound (SR-3). Psychoneuroendocrinology 29 (2004) 113-124
17. Taha A.Y., Filo E., Ma D.W., and McIntyre B.W. Dose-dependent anticonvulsant effects of linoleic and alpha-linolenic polyunsaturated fatty acids on pentylenetetrazol induced seizures in rats. Epilepsia (2008)
18. Vreugdenhil M., Bruehl C., Voskuyl R.A., Kang J.X., Leaf A., and Wadman W.J. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc Natl Acad Sci USA 93 (1996) 12559-12563
19. Xiao Y., and Li X. Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation. Brain Res 846 (1999) 112-121
20. Yehuda S., Carasso R.L., and Mostofsky D.I. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur J Pharmacol 254 (1994) 193-198
21. Young C., Gean P.W., Chiou L.C., and Shen Y.Z. Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in the rat hippocampus. Synapse 37 (2000) 90-94
22. Fraser D.D., Whiting S., Andrew R.D., Macdonald E.A., Musa-Veloso K., and Cunnane S.C. Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet. Neurology 60 (2003) 1026-1029
23. Dahlin M., Hjelte L., Nilsson S., and Amark P. Plasma phospholipid fatty acids are influenced by a ketogenic diet enriched with n-3 fatty acids in children with epilepsy. Epilepsy Res 73 (2007) 199-207
24. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226 (1957) 497-509
25. Bodenant M., Moreau C., Sejourne C., Auvin S., Delval A., Cuisset J.M., et al. Interest of the ketogenic diet in a refractory status epilepticus in adults. Rev Neurol (Paris) 164 (2008) 194-199
26. Voskuyl R.A., Vreugdenhil M., Kang J.X., and Leaf A. Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. Eur J Pharmacol 341 (1998) 145-152
27. Bromfield E., Dworetzky B., Hurwitz S., Eluri Z., Lane L., Replansky S., et al. A randomized trial of polyunsaturated fatty acids for refractory epilepsy. Epilepsy Behav 12 (2008) 187-190
28. Schlanger S., Shinitzky M., and Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 43 (2002) 103-104
29. Yuen A.W., Sander J.W., Fluegel D., Patsalos P.N., Bell G.S., Johnson T., et al. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy Behav 7 (2005) 253-258
30. Willis S., Samala R., Rosenberger T.A., and Borges K. Eicosapentaenoic and docosahexaenoic acids are not anticonvulsant or neuroprotective in acute mouse seizure models. Epilepsia (2008)
31. Keros S., and McBain C.J. Arachidonic acid inhibits transient potassium currents and broadens action potentials during electrographic seizures in hippocampal pyramidal and inhibitory interneurons. J Neurosci 17 (1997) 3476-3487
32. + channels: subunit selective antagonism by zinc. Neuropharmacology 35 (1996) 969-982